세계의 소변 검사 시장 규모 : 유형별, 용도별, 최종 사용자별, 지역별, 범위 및 예측

Urinalysis Market Size and Forecast

Urinalysis Market size was valued at USD 2.07 Billion in 2023 and is projected to reach USD 3.91 Billion by 2031 , growing at a CAGR of 8.30% from 2024 to 2031. urinalysis refers to a diagnostic process that examines urine samples to assess health status, detect diseases, and monitor various medical conditions. This analysis is widely utilized in clinical laboratories and healthcare settings for diagnosing conditions such as urinary tract infections, kidney diseases, diabetes, and liver disorders.

The future of urinalysis is promising, with advancements in technology driving innovation in testing methods, including the development of point-of-care testing devices and automated urinalysis systems.

Global Urinalysis Market Dynamics

The key market dynamics that are shaping the global urinalysis market include:

Key Market Drivers

Rising Incidence of Urinary Tract Infections (UTIs):

Approximately 150 million urinary tract infections occur globally each year, creating a significant demand for urinalysis to diagnose and manage these conditions effectively.

Growing Prevalence of Diabetes:

With an estimated 537 million adults worldwide living with diabetes as of 2021, the need for regular urinalysis to monitor glucose levels and prevent complications is increasing, further driving market growth.

Technological Advancements:

The global market for point-of-care testing devices is projected to reach $60.6 billion by 2025, fostering innovation in urinalysis technology and expanding its applications in various healthcare settings.

Emphasis on Preventive Healthcare:

Governments and health organizations are increasingly promoting preventive healthcare measures, with global healthcare expenditure projected to reach $10 trillion by 2022, which supports the growth of routine diagnostic tests, including urinalysis.

Key Challenges

Accuracy and Reliability Concerns:

Variability in results due to human error or improper sample handling can affect the accuracy of urinalysis, posing challenges in clinical decision-making.

Regulatory Compliance:

Stringent regulatory standards and guidelines for diagnostic tests can complicate the approval process for new urinalysis devices and technologies.

High Cost of Advanced Technologies:

The adoption of automated and advanced urinalysis systems can be hindered by their high costs, limiting access for smaller healthcare facilities.

Limited Awareness in Emerging Markets:

There is often a lack of awareness and education regarding the importance of urinalysis in healthcare, particularly in developing regions, which can restrict market growth.

Key Trends:

Integration of Artificial Intelligence (AI):

The incorporation of AI and machine learning algorithms into urinalysis processes is enhancing the interpretation of results, improving diagnostic accuracy, and streamlining workflows.

Rise of Home-Based Testing:

Increasing consumer demand for at-home health monitoring solutions is leading to the development of user-friendly urinalysis kits that allow individuals to conduct tests in the comfort of their homes.

Personalized Medicine Approaches:

There is a growing trend towards personalized medicine, where urinalysis is being integrated into tailored healthcare plans, enabling better disease management and monitoring.

Expansion of Telehealth Services:

The rise of telehealth platforms is facilitating remote consultations and monitoring, increasing the accessibility of urinalysis services and allowing for timely intervention and management of health conditions.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Urinalysis Market Regional Analysis

Here is a more detailed regional analysis of the global urinalysis market:

North America:

North America is the dominant region in the global urinalysis market, accounting for a significant share due to its well-established healthcare infrastructure, advanced diagnostic technologies, and high awareness of preventive healthcare. The region's strong emphasis on early disease detection and management contributes to the widespread adoption of urinalysis tests in clinical settings. According to the Centers for Disease Control and Prevention (CDC), approximately 70% of all healthcare decisions are based on laboratory test results, highlighting the critical role of urinalysis in patient care.

The presence of major market players, robust research and development activities, and a strong regulatory framework further enhance North America's market position. The U.S. Food and Drug Administration (FDA) has approved numerous innovative urinalysis products, ensuring that healthcare providers have access to advanced testing solutions. The region's focus on personalized medicine and rapid technological advancements, including point-of-care testing, also bolster the growth of the urinalysis market.

Asia Pacific:

The Asia Pacific region is the fastest-growing market for urinalysis, driven by a combination of increasing healthcare expenditures, a rising population, and growing awareness of preventive healthcare measures. Rapid urbanization and economic growth in countries like China and India have led to a surge in demand for diagnostic testing services, including urinalysis. According to the World Health Organization (WHO), healthcare spending in Asia Pacific is projected to reach $2.4 trillion by 2025, reflecting a strong commitment to improving healthcare access and quality.

The rising prevalence of lifestyle-related diseases, such as diabetes, hypertension, and obesity, is further propelling the demand for urinalysis in the region. For instance, the International Diabetes Federation (IDF) estimates that the number of adults with diabetes in the Asia Pacific region will rise to over 200 million by 2030, necessitating regular monitoring through urinalysis. This growing disease burden creates significant opportunities for market players to introduce innovative testing solutions tailored to the region's specific health challenges.

Global Urinalysis Market Segmentation Analysis

The Global Urinalysis Market is segmented on the basis of By Type, By Application, By End User and By Geography.

Urinalysis Market, By Type

• Instruments
• Consumables

Based on Type, the Global Urinalysis Market is segmented into Instruments and Consumables. The Instruments is the dominate segment due to the widespread adoption of automated urinalysis systems and analyzers in hospitals and diagnostic laboratories. These instruments offer enhanced accuracy and efficiency in urine testing, making them a crucial part of the diagnostic process. However, the consumables segment is the fastest-growing, driven by the rising demand for test strips, reagents, and disposable items used in both traditional and point-of-care testing.

Urinalysis Market, By Application

• Disease Screening
• Pregnancy and Fertility Kits

Based on Application, the Global Urinalysis Market is segmented into Disease Screening and Pregnancy & Fertility Kits. The disease screening segment is the dominant segment, driven by its widespread use in detecting conditions such as urinary tract infections, kidney disorders, and diabetes. On the other hand, the pregnancy and fertility kits segment is the fastest-growing, owing to the increasing demand for at-home testing kits that offer convenience and privacy.

Urinalysis Market, By End User

• Clinical Laboratories
• Hospitals
• Home Care

Based on End User, the Global Urinalysis Market is segmented into Disease Screening and Pregnancy & Fertility Kits. The clinical laboratories is the dominating segment due to the widespread use of advanced diagnostic equipment and the high volume of tests conducted in these facilities. On the other hand, the home care segment is the fastest-growing, driven by the increasing demand for at-home diagnostic solutions and the rise of point-of-care testing.

Urinalysis Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the Global Urinalysis Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the global urinalysis market, accounting for a significant share due to its well-established healthcare infrastructure, advanced diagnostic technologies, and high awareness of preventive healthcare. The Asia Pacific region is the fastest-growing market for urinalysis, driven by a combination of increasing healthcare expenditures, a rising population, and growing awareness of preventive healthcare measures.

Key Players

• The "Global Urinalysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
• Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific, Bayer AG, F. Hoffmann-La Roche Ltd, Beckman Coulter Life Sciences, Alfa Wassermann Inc., EKF Diagnostics, Trinity Biotech plc, Arkray, Mindray Medical International Limited, and more.
• Our
• market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
• Global Urinalysis Market: Recent Developments
• In August 2023 Siemens Healthineers announced its acquisition of a cutting-edge urinalysis technology firm focused on developing point-of-care testing solutions.
• In July 2023 Becton, Dickinson and Company (BD) launched a new line of enhanced urinalysis reagents, designed to improve the sensitivity and specificity of urinalysis tests.
• In June 2023 Abbott announced a strategic partnership with a HealthTech startup specializing in digital health solutions for urinalysis. This collaboration aims to develop a mobile application that allows patients to conduct at-home urinalysis tests and receive real-time feedback on their results.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL URINALYSIS MARKET

• 1.1 Market Definition
• 1.2 Market Segmentation
• 1.3 Research Timelines
• 1.4 Assumptions
• 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 2.1 Data Mining
• 2.2 Data Triangulation
• 2.3 Bottom-Up Approach
• 2.4 Top-Down Approach
• 2.5 Research Flow
• 2.6 Key Insights from Industry Experts
• 2.7 Data Sources

3 EXECUTIVE SUMMARY

• 3.1 Market Overview
• 3.2 Ecology Mapping
• 3.3 Absolute Market Opportunity
• 3.4 Market Attractiveness
• 3.5 Global Urinalysis Market Geographical Analysis (CAGR %)
• 3.6 Global Urinalysis Market, By Type (USD Million)
• 3.7 Global Urinalysis Market, By Application (USD Million)
• 3.8 Global Urinalysis Market, By End-User (USD Million)
• 3.9 Future Market Opportunities
• 3.10 Global Market Split
• 3.11 Product Life Line

4 GLOBAL URINALYSIS MARKET OUTLOOK

• 4.1 Global Urinalysis Evolution
• 4.2 Drivers
  • 4.2.1 Driver 1
  • 4.2.2 Driver 2
• 4.3 Restraints
  • 4.3.1 Restraint 1
  • 4.3.2 Restraint 2
• 4.4 Opportunities
  • 4.4.1 Opportunity 1
  • 4.4.2 Opportunity 2
• 4.5 Porters Five Force Model
• 4.6 Value Chain Analysis
• 4.7 Pricing Analysis
• 4.8 Macroeconomic Analysis

5 GLOBAL URINALYSIS MARKET, BY TYPE

• 5.1 Overview
• 5.2 Cartridges & Capsules
• 5.3 Syringe Filters
• 5.4 Bottle-Top Vacuum Filters
• 5.5 Others

6 GLOBAL URINALYSIS MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Instruments
• 6.3 Consumables

7 GLOBAL URINALYSIS MARKET, BY END-USER

• 7.1 Overview
• 7.2 Clinical Laboratories
• 7.3 Hospitals
• 7.4 Home Care
• 7.5 Others

8 GLOBAL URINALYSIS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Argentina
  • 8.5.3 Rest of Latin America
• 8.6 Middle-East and Africa
  • 8.6.1 UAE
  • 8.6.2 Saudi Arabia
  • 8.6.3 South Africa
  • 8.6.4 Rest of Middle-East and Africa

9 GLOBAL URINALYSIS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Developments
• 9.4 Company Regional Footprint
• 9.5 Company Industry Footprint
• 9.6 ACE Matrix

10 COMPANY PROFILES

• 10.1 Cardinal Health
  • 10.1.1 Company Overview
  • 10.1.2 Company Insights
  • 10.1.3 Product Benchmarking
  • 10.1.4 Key Development
  • 10.1.5 Winning Imperatives
  • 10.1.6 Current Focus & Strategies
  • 10.1.7 Threat from Competition
  • 10.1.8 SWOT Analysis
• 10.2 Roche Diagnostics
  • 10.2.1 Company Overview
  • 10.2.2 Company Insights
  • 10.2.3 Product Benchmarking
  • 10.2.4 Key Development
  • 10.2.5 Winning Imperatives
  • 10.2.6 Current Focus & Strategies
  • 10.2.7 Threat from Competition
  • 10.2.8 SWOT Analysis
• 10.3 Sysmex Corporation
  • 10.3.1 Company Overview
  • 10.3.2 Company Insights
  • 10.3.3 Product Benchmarking
  • 10.3.4 Key Development
  • 10.3.5 Winning Imperatives
  • 10.3.6 Current Focus & Strategies
  • 10.3.7 Threat from Competition
  • 10.3.8 SWOT Analysis
• 10.4 Beckman Coulter
  • 10.4.1 Company Overview
  • 10.4.2 Company Insights
  • 10.4.3 Product Benchmarking
  • 10.4.4 Key Development
  • 10.4.5 Winning Imperatives
  • 10.4.6 Current Focus & Strategies
  • 10.4.7 Threat from Competition
  • 10.4.8 SWOT Analysis
• 10.5 Arkray Inc.Abbott
  • 10.5.1 Company Overview
  • 10.5.2 Company Insights
  • 10.5.3 Product Benchmarking
  • 10.5.4 Key Development
  • 10.5.5 Winning Imperatives
  • 10.5.6 Current Focus & Strategies
  • 10.5.7 Threat from Competition
  • 10.5.8 SWOT Analysis
• 10.6 Siemens Healthcare GmbH
  • 10.6.1 Company Overview
  • 10.6.2 Company Insights
  • 10.6.3 Product Benchmarking
  • 10.6.4 Key Development
  • 10.6.5 Winning Imperatives
  • 10.6.6 Current Focus & Strategies
  • 10.6.7 Threat from Competition
  • 10.6.8 SWOT Analysis
• 10.7 ACON Laboratories
  • 10.7.1 Company Overview
  • 10.7.2 Company Insights
  • 10.7.3 Product Benchmarking
  • 10.7.4 Key Development
  • 10.7.5 Winning Imperatives
  • 10.7.6 Current Focus & Strategies
  • 10.7.7 Threat from Competition
  • 10.7.8 SWOT Analysis
• 10.8 Shenzhen Mindray Bio-Medical Electronics
  • 10.8.1 Company Overview
  • 10.8.2 Company Insights
  • 10.8.3 Product Benchmarking
  • 10.8.4 Key Development
  • 10.8.5 Winning Imperatives
  • 10.8.6 Current Focus & Strategies
  • 10.8.7 Threat from Competition
  • 10.8.8 SWOT Analysis
• 10.9 F. Hoffmann-La Roche
  • 10.9.1 Company Overview
  • 10.9.2 Company Insights
  • 10.9.3 Product Benchmarking
  • 10.9.4 Key Development
  • 10.9.5 Winning Imperatives
  • 10.9.6 Current Focus & Strategies
  • 10.9.7 Threat from Competition
  • 10.9.8 SWOT Analysis
• 10.10 Quidel Corporation
  • 10.10.1 Company Overview
  • 10.10.2 Company Insights
  • 10.10.3 Product Benchmarking
  • 10.10.4 Key Development
  • 10.10.5 Winning Imperatives
  • 10.10.6 Current Focus & Strategies
  • 10.10.7 Threat from Competition
  • 10.10.8 SWOT Analysis
• 10.11 Bio-Rad Laboratories
  • 10.11.1 Company Overview
  • 10.11.2 Company Insights
  • 10.11.3 Product Benchmarking
  • 10.11.4 Key Development
  • 10.11.5 Winning Imperatives
  • 10.11.6 Current Focus & Strategies
  • 10.11.7 Threat from Competition
  • 10.11.8 SWOT Analysis
• 10.12 Urit Medical Electronics
  • 10.12.1 Company Overview
  • 10.12.2 Company Insights
  • 10.12.3 Product Benchmarking
  • 10.12.4 Key Development
  • 10.12.5 Winning Imperatives
  • 10.12.6 Current Focus & Strategies
  • 10.12.7 Threat from Competition
  • 10.12.8 SWOT Analysis
• 10.13 77 Elektronika Kft.
  • 10.13.1 Company Overview
  • 10.13.2 Company Insights
  • 10.13.3 Product Benchmarking
  • 10.13.4 Key Development
  • 10.13.5 Winning Imperatives
  • 10.13.6 Current Focus & Strategies
  • 10.13.7 Threat from Competition
  • 10.13.8 SWOT Analysis
• 10.14 Mindray Medical International Limited
  • 10.14.1 Company Overview
  • 10.14.2 Company Insights
  • 10.14.3 Product Benchmarking
  • 10.14.4 Key Development
  • 10.14.5 Winning Imperatives
  • 10.14.6 Current Focus & Strategies
  • 10.14.7 Threat from Competition
  • 10.14.8 SWOT Analysis

11. VERIFIED MARKET INTELLIGENCE

• 11.1 About Verified Market Intelligence
• 11.2 Dynamic Data Visualization